Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients-Reference-Cited by-同舟云学术

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients

Published:2023-04-21 Issue:8 Volume:72 Page:2687-2700
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bordignon María B.,Pesce Viglietti Ayelén I.,Juliá Estefanía P.,Sanchez María B.,Rölle Alexander,Mandó Pablo,Sabatini Luciana,Ostinelli Alexis,Rizzo Manglio M.,Barrio María M.,Mordoh José,Fainboim Leonardo,Levy Estrella M.

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-023-03448-w.pdf

Reference45 articles.

1. Cardoso F, Kyriakides S, Ohno S et al (2019) Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol 30:1194–1220. https://doi.org/10.1093/annonc/mdz173

2. Scheuer W, Friess T, Burtscher H et al (2009) Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res 69:9330–9336. https://doi.org/10.1158/0008-5472.CAN-08-4597